M

Mazowieckie Centrum Badan Klinicznych | Grodzisk Mazowiecki, Poland

Research site

(Unclaimed)

Location

Daleka 32, Grodzisk Mazowiecki, Mazovia, Poland

Site insights

Top conditions

Top treatments

R935788

BFB759

RTX-GRT7039

Ocrelizumab

Povorcitinib

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

3 of 5 total trials

A Study Evaluating BFB759 in Moderate to Severe Atopic Dermatitis (COMPASS 2-AD)

This is a double-blind, placebo-controlled study where subjects are participating for approximately 36 to 40 weeks. The study compares how well BFB75...

Enrolling

Atopic Dermatitis (AD)

Biological: BFB759

Drug: Placebo

A Study to Evaluate the Efficacy and Safety of Ocrelizumab in Adults With Primary Progressive Multiple Sclerosis (O'HAND)

This study will evaluate the efficacy and safety of ocrelizumab (Ocrevus®) compared with placebo in participants with primary progressive multiple sc...

Active, not recruiting

Multiple Sclerosis, Primary Progressive

Drug: Ocrelizumab

Drug: Placebo